Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDE | P14735 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | MEN1 | O00255 | 7/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1196117 | 1.00 | IDE (0.58) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL68503 | 0.87 | IDE (0.71) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL68504 | 0.87 | IDE (0.71) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL522970 | 0.81 | IDE (0.59) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL31189839 | 0.81 | IDE (0.59) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL522969 | 0.81 | IDE (0.59) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL2481541 | 0.79 | IDE (0.79) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL18768620 | 0.79 | IDE (0.58) | IDEALDH1A1ALOX15MYCMAPT | |
| SCHEMBL169230 | 0.79 | IDE (0.79) | IDEALDH1A1ALOX15MYCMAPT | |
| Phenol SCHEMBL7057355 | 0.79 | IDE (0.79) | IDEALDH1A1ALOX15MYCMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1877434-A2 | MODIFIED INTERFERON-GAMMA POLYPEPTIDES AND METHODS FOR USING MODIFIED INTERFERON-GAMMA POLYPEPTIDES | Nautilus Biotech (FR) | 2008-01-16 | — | — | EP | claimed |
| CN-101094865-A | Modified growth hormones | NAUTILUS BIOTECH (FR) | 2007-12-26 | — | — | CN | claimed |
| EP-1807449-A2 | MODIFIED GROWTH HORMONES | Nautilus Biotech (FR) | 2007-07-18 | — | — | EP | claimed |
| WO-2006120580-A2 | MODIFIED INTERFERON-GAMMA POLYPEPTIDES AND METHODS FOR USING MODIFIED INTERFERON-GAMMA POLYPEPTIDES | NAUTILUS BIOTECH (FR) | 2006-11-16 | — | — | WO | claimed |
| US-20060251619-A1 | Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2006-11-09 | — | — | US | claimed |
| WO-2006048777-A2 | MODIFIED GROWTH HORMONES | NAUTILUS BIOTECH (US) | 2006-05-11 | — | — | WO | claimed |
| WO-2023250371-A1 | ANTIBODY BASED TREATMENT TO REDUCE GUT BACTERIAL GLYCAN AND ASSOCIATED BACTERIA | NEW YORK UNIVERSITY (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20220184196-A1 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2022-06-16 | — | — | US | disclosed |
| US-11241488-B2 | Methods and compositions for treating and diagnosing autoimmune diseases | NEW YORK UNIVERSITY (US) | 2022-02-08 | — | — | US | disclosed |
| US-20200061176-A1 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2020-02-27 | — | — | US | disclosed |
| WO-2018209149-A1 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2018-11-15 | — | — | WO | disclosed |
| US-9475263-B1 | Breathable chemical, biological, radiation, and/or nuclear protection fabric or material | MATERIALS MODIFICATION, INC. (US) | 2016-10-25 | — | — | US | disclosed |
| EP-2476700-A1 | Modified growth hormones | HanAll Biopharma Co., Ltd. (KR) | 2012-07-18 | — | — | EP | disclosed |
| US-20070249532-A9 | Modified growth hormones | HANALL BIOPHARMA CO., LTD. (KR) | 2007-10-25 | — | — | US | disclosed |
| WO-2007110231-A2 | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES | NAUTILUS BIOTECH, S.A. (FR) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007092029-A2 | CATALYTIC NANOPARTICLES FOR NERVE-AGENT DESTRUCTION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-08-16 | — | — | WO | disclosed |
| WO-2006120580-A2 | MODIFIED INTERFERON-GAMMA POLYPEPTIDES AND METHODS FOR USING MODIFIED INTERFERON-GAMMA POLYPEPTIDES | NAUTILUS BIOTECH (FR) | 2006-11-16 | — | — | WO | disclosed |
| US-20060251619-A1 | Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2006-11-09 | — | — | US | disclosed |
| US-20060247170-A1 | Modified growth hormones | GUYON THIERRY | 2006-11-02 | — | — | US | disclosed |
| US-20060094655-A1 | Modified growth hormones | GUYON THIERRY | 2006-05-04 | — | — | US | disclosed |